Importantly, these compounds reduced the fraction of CSCs (CD133+/EpCAM+), the expression of stemness markers (NANOG or OCT4 proteins), and the ability of HCC cells to form spheres. This evidence concerns the gene EPCAM and hepatocellular carcinoma.